According to Merck's latest financial reports and stock price the company's current number of shares outstanding is 2,535,293,793. At the end of 2023 the company had 2,535,293,793 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 2.53 B | -0.03% |
2022 | 2.53 B | 0.36% |
2021 | 2.52 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,407,178,000 | -5.05% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,062,000,000 | -18.67% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,646,000,000 | 122.70% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 1,735,357,980 | -31.55% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 949,303,000 | -62.56% | ๐บ๐ธ USA |
![]() Amgen AMGN | 535,000,000 | -78.90% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,506,400,000 | -1.14% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | 2,057,000,000 | -18.87% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,027,500,000 | -20.03% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 1,121,000,000 | -55.78% | ๐ฎ๐ฑ Israel |